DSM-5 and clinical trials in psychiatry:challenges to come?
Nature Reviews Drug Discovery 11,583 (2012).
doi:10.1038/nrd3811
Authors:Florence Butlen-Ducuing,Manuel Haas,Luca Pani,Barbara van Zwieten-Boot &Karl Broich
The publication of the fifth version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) in 2013 raises important questions for clinical trials and associated regulatory decisions on new drugs for psychiatric disorders.
Nature Reviews Drug Discovery –Issue –nature.com science feeds
